• home
  • blog
  • services
  • technical help
  • news archive
  • about
  • contact
  • sitemap

Outsourcing Services: Drug Discovery and Structural Biology Platform


SARomics Biostructures offers a drug discovery platform with full-range drug discovery and structural biology outsourcing services for the biotech and pharmaceutical industry, as well as for non-profit institutions. Our strategic location at the MAX-lab synchrotron radiation facility in Lund, Sweden, provides us with instant access to beamlines and eliminates the need for crystal transportation to remote synchrotrons.

Learn more about how we can accelerate your discovery project using the tools of structural biology and structural bioinformatics. Our technologies help pages are designed to provide the information required for planning your experiments.
Please
Contact us for the discussions of your project!

  • Drug Discovery
• Library design
•
in silico discovery
• Fragment library screening
• SBDD
• Hit-to-lead optimization
• QSAR analysis
• ADME modeling
• Protein optimization


  • X-ray Crystallography
• Gene to structure
•
Crystallization
•
Structure determination
• Off-the-shelf structures
• Protein characterization
• Ligand complex structures

  • NMR Spectroscopy
• Structure determination
•
Binding assays
• Fragment screening
• Structural integrity test
• pKa determination


Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.


Highlights

Off-the-shelf structures
SARomics Biostructures and its partners release the first off-the-shelf structures.
Read more...

January 2012
SARomics Biostructures CEO Björn Walse will make a presentation entitled ”Kinase inhibitors: A new era of targeted therapies?” at the "
Future of Swedish & Danish Life Sciences" event at Medicon Village in Lund on March 28.

January 2012
SARomics Biostructures, together with AstraZeneca and researchers at the Royal Institute of Technology determined several crystal structures revealing major structural rearrangements of a bacterial transaminase important for biocatalysis of industrially important transamination reactions.
Read more ...

News archive»

Testimonials

"Our first experience with SARomics has been amazing. Two days after we had handed over our protein for crystallization, we were told that crystals had already appeared. We have experienced very professional service from the company. Being in Lund, we are also able to follow the structural refinements with regular meetings. We hope to continue working with Saromics as and when the need arises."

Professor Rajn Hatti Kaul , Deprtment of Biotechnology, Lund University

"Collaborating with SARomics has been exceptionally positive and productive. Data of outstanding quality were collected and refined to extremely high resolution, as was professional experimental documentation. We also greatly appreciated the continuous communication and project progress updates. In future biostructural projects, we will certainly choose to work with SARomics again."

Professor Ulf Nilsson, Lund University, co-founder of Galecto Biotech

“We have a very productive collaboration with SARomics, using their technology to accelerate our ongoing discovery process.”

Senior Director of preclinical R&D Dr. Oreola Donini, Inimex Pharmaceuticals

Protein Crystallization Services, Crystallography and Drug Design:: SARomics Biostructures AB • P.O. Box 724 • SE-220 07 Lund • Sweden • Tel.+46 46 191276 • © 2012 •